Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

oxybiciron MeSH Supplementary Concept Data 2025


MeSH Supplementary
oxybiciron
Unique ID
C008741
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C008741
Registry Numbers
78371-68-3
CAS Type 1 Name
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-, mixture with 4,5-dihydro-N-(5,6,7,8-tetrahydro-1-naphthalenyl)-1H-imidazol-2-amine monohydrochloride
Heading Mapped to
Drug Combinations
*Imidazoles
*Oxytetracycline
Frequency
0
Note
100 mls contain 0.6344g oxytetracycline, 0.0585g tramazoline
Source
Med Welt 24(27/28):1145;1973
Indexing Information
Ophthalmic Solutions
Date of Entry
1974/01/01
Revision Date
1982/07/28
oxybiciron Preferred
page delivered in 0.004s